CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishObjective. This article examines the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: minimum efficacy standards (MES) and a mix of MES and price control mechanisms (MES + PC). Data Sources. Our primary data source is the Tufts-New England Medical Center-Cost Effectiveness Analysis Registry which have been merged with price data taken from MEPS (for the United States) and AIFA (for Italy). Study Design. Through a simple model of adverse selection we model the interaction between firms, heterogeneous buyers, and the regulator. Principal Findings. The theoretical analysis provides two results. First, an MES regime provides greater incentives to produce high-quality drugs. Second, an MES + PC mix reduces the difference in price between the highest and lowest quality drugs on the market. Conclusion. The empirical analysis based on United States and Italian data corroborates these results.
Atella, V., Bhattacharya, J., & Carbonari, L. (2011). Pharmaceutical price controls and minimum efficacy regulation: evidence from the United States and Italy. HEALTH SERVICES RESEARCH, 47(1, pt 1), 293-308 [10.1111/j.1475-6773.2011.01333.x].
| Tipologia: | Articolo su rivista | |
| Citazione: | Atella, V., Bhattacharya, J., & Carbonari, L. (2011). Pharmaceutical price controls and minimum efficacy regulation: evidence from the United States and Italy. HEALTH SERVICES RESEARCH, 47(1, pt 1), 293-308 [10.1111/j.1475-6773.2011.01333.x]. | |
| IF: | Con Impact Factor ISI | |
| Lingua: | English | |
| Settore Scientifico Disciplinare: | Settore SECS-P/01 - Economia Politica | |
| Revisione (peer review): | Esperti anonimi | |
| Tipo: | Articolo | |
| Rilevanza: | Rilevanza internazionale | |
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1111/j.1475-6773.2011.01333.x | |
| Stato di pubblicazione: | Pubblicato | |
| Data di pubblicazione: | dic-2011 | |
| Titolo: | Pharmaceutical price controls and minimum efficacy regulation: evidence from the United States and Italy | |
| Autori: | ||
| Autori: | Atella, V; Bhattacharya, J; Carbonari, L | |
| Appare nelle tipologie: | 01 - Articolo su rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| Health Services Research - Wiley Online Library.pdf | Versione Editoriale (PDF) | Copyright dell'editore | UNIVERSITY_NETWORK Richiedi una copia |
http://hdl.handle.net/2108/52073
Copyright © 2022